Imagentix Offers Extension of Warrants( Warrant Holders to...),Health

Warrant Holders to Pay $.05 to Extend

Call Provision to be Changed

SAN DIEGO, Oct. 23 /PRNewswire-FirstCall/ -- Imagenetix, Inc. (OTC Bulletin Board: IAGX), announced today that its Board of Directors have approved the extending of several series of warrants that are scheduled to expire on October 23, 2007. The majority of these warrants have an exercise price from $1.00 to $2.00

Warrant holders will have the right to have their warrants extended until October 23, 2010 provided they pay to the Company $.05 per warrant no later than November 30, 2007. Those who elect to extend shall have the $.05 payment deducted from their exercise price. In addition, the Company will now have the right to call any series of warrants if the stock should trade at a 20% premium to the exercise price for 10 business days.

Commenting on the extension, Mr. William Spencer, President of Imagentix said, "We have decided to give our warrant holders, who are mostly long term supporters of the Company, the opportunity to extend their warrants if they should choose. By changing the call provision it will allow the Company to call warrants as the stock price increases if the Company needs additional capital to expand branding of its retail products."

About Imagenetix

Based in San Diego, California, Imagenetix, (OTC Bulletin Board: IAGX) is an innovator of scientifically tested, natural-based, proprietary bioceutical products developed to enhance human health on a global basis. Imagenetix develops, formulates and private-labels propriety over-the-counter topical creams, skincare products and nutritional supplements to be marked globally through multiple channels of distribution. In addition, the company develops patentable compounds for entering into licensing agreements with pharmaceutical partners. Imagenetix is the creator of Inflame Away(TM)- Celadrin(R), which has been clinically tested to relieve osteoarthritis
'/>"/>